London, ON - Defibrillation-threshold (DFT) testing performed on a routine basis at ICD implantation is unlikely to significantly affect one- or five-year mortality, according to a statistical ...
Dallas, TX - Antiarrhythmic agents used with today's implantable cardioverter defibrillators (ICDs), particularly amiodarone, don't raise successful-shock energy requirements enough to make ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Routine defibrillation testing appears to be safe, but does not improve outcomes in patients ...
CHICAGO, IL—Defibrillation testing (DFT) is not always necessary in patients receiving a subcutaneous implantable cardioverter defibrillator (S-ICD) when using a scoring system that assesses the ...
Defibrillation testing of implantable cardioverter–defibrillators (ICDs) does not improve outcomes compared with device implantation without testing and, therefore, “defibrillation testing during ...